Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lexagene Holdings Inc LXXGQ

Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.


GREY:LXXGQ - Post by User

Comment by 007daveon Feb 20, 2021 1:30pm
186 Views
Post# 32619068

RE:POC

RE:POCBeen a long term share holder for three years now and finally sold my remaining shares this week. I basically ran out of faith and patience in the company to take advantage of Covid and bring a machine to market. Missed time lines, lack of news flow and fluffy news releases killed the stock in the summer and fall in my opinion. LXG should be north of 5 dollars by now. I think watching Carol Baskins promo was the last straw for me. LXG is not the only poc machine in development for the market right now. Millions of at home rapid tests kits are now available for home use and other commercial uses, like the film industry. In my opinion the biggest problem I see with Lexagenes machine is the lack of testing capacity. One machine one test one hour. Doesn't work in a hospital or clinical setting unless they have a series of dozens of machines for mass patient testing. Lexagene hasn't even announced a manufacturer yet to supply the market when and if they get approved by FDA for the poc market. I may be kicking myself for selling or I may buy back in as I watch the stock price slowly errode like it has sooo many times in the past.
<< Previous
Bullboard Posts
Next >>